TORONTO and DUEREN, Germany, Sept. 22, 2021 /CNW/ - GBLT Corp. (TSXV: GBLT) (OTCQB: GBLTF) (FSE: 4G9) ("GBLT" or the "Company") is pleased to announce that it has received an order for €2.1m (CDN $3.2m) from Europe's largest retailer to deliver the Company's newest product line, Dr. Senst branded blood pressure monitors and nebulizers. Products will be sold in markets that include France, Spain, Portugal and Italy and GBLT expects to distribute these products in additional markets going forward.
This order marks continued expansion of GBLT's proprietary brand of Dr. Senst healthcare electronic products as the Company continues to penetrate retailers globally.
"The fact that Europe's largest retailer is coming directly to GBLT to have products developed based on consumer demand, is a testament to our relationship with our clients and our ability to deliver exactly what our clients are looking for in a timely and cost effective manner," said Dr. Thilo Senst, Founder and CEO of GBLT Corp. "Dr. Senst has become a leading and trusted European brand in just a short 18-month period and we continue to quickly expand our product lines to meet the demand of customers. We are well on track to achieve record revenue in fiscal year 2021, but further sustain this growth moving forward, independent of COVID-19, as the Dr. Senst brand quickly becomes a trusted household brand of products for today's more health-concious consumer."